EBITDA Add-Backs in LBO Underwriting

When a private-equity sponsor buys a company using leverage, underwriters don’t use the company’s reported EBITDA to measure its cash flow and debt capacity. Instead, they construct a pro-forma EBITDA by adding back one-time costs, corporate allocations, and expected savings—a practice known as EBITDA add-backs in LBO underwriting. These adjustments can inflate the apparent cash flow by 20–40 percent, allowing sponsors to justify much larger loans than the company’s actual standalone earnings would support. The risk is that synergies never materialize, or one-time costs recur, and the company cannot service its debt.

Why Sponsors Add Back: The Math of Leverage

The purpose of add-backs is to convert reported EBITDA into a “run-rate” or “pro-forma” EBITDA that reflects the cash-generation potential of the business under new ownership.

Consider a $500 million acquisition. The company reported EBITDA of $50 million last year. If underwriters use $50 million as the baseline, they can support a loan at, say, 5 times EBITDA—a $250 million loan. But the buyer says: “The previous owner was inefficient. I can cut corporate overhead by $3 million, renegotiate supplier contracts for $2 million in savings, and eliminate redundant headcount at $2 million. That’s $7 million more EBITDA, bringing us to $57 million, which supports a $285 million loan—meaning less equity required.”

At 5.7 times the new EBITDA, the math works. The sponsor can fund the deal with $215 million of equity instead of $250 million—a 14 percent saving in capital required, which improves the sponsor’s potential returns.

This is legitimate if the adjustments are realistic and achievable. The problem arises when adjustments are aggressive, speculative, or conflate one-time savings with recurring improvements.

The Main Categories of Add-Backs

One-Time or Non-Recurring Costs

The most defensible add-back is for costs that genuinely should not recur. If a company spent $1.5 million last year on severance during a restructuring under the previous owner, and the new sponsor will not incur severance, that $1.5 million can reasonably be added back—the company’s normalized run-rate EBITDA is higher than last year’s reported figure.

Similarly, costs related to being a public company, or a subsidiary of a larger corporation, may not apply post-acquisition. Costs to comply with a parent’s reporting and audit requirements, or one-time costs of separating from a parent, can be added back.

Corporate Overhead Allocations

Parent-company allocations are frequently added back. If the target was a subsidiary, it was charged for corporate services—finance, IT, HR, legal—at rates set by the parent. Under new (typically smaller and leaner) ownership, these costs may be lower.

The risk is aggressive assumptions. A sponsor might assume that corporate overhead falls to $1 million annually post-acquisition, but integrating the target into the sponsor’s holding company structure may not actually save much. The sponsor’s own IT team needs to set up new servers; the finance team needs to learn the new company’s accounting system. Real synergies exist, but they are often 50–70 percent of the estimated savings.

Cost of Goods Sold (COGS) Improvements

When a sponsor believes it can improve manufacturing efficiency, vendor discounts, or supply-chain management, it adds back the expected savings. A company pays $2 million more for materials than it should because suppliers know the company is unsophisticated. The sponsor, using its own global vendor relationships, can cut that to $1.2 million—a $800,000 COGS add-back.

This is plausible, but it competes with other add-backs and risks compounding. If both the sponsor and the lender assume 15 percent COGS savings, but also assume 10 percent SG&A savings from consolidation, and also assume 5 percent improvement in working capital, the total pro-forma adjustment can be 25–30 percent. Achieving 25–30 percent is far harder than achieving any one of them.

Synergy and Cost-Reduction Assumptions

The most speculative add-back is a synergy that depends on the sponsor’s successful integration or operational improvements. A typical assumption: “Under new management, the company will achieve 3 percent annual revenue growth, and gross margins will improve from 35 percent to 37 percent due to operational excellence.”

These are not one-time savings; they are permanent, ongoing improvements. If achieved, they are valuable. If not, the debt capacity evaporates. A lender will scrutinize whether the sponsor has successfully driven similar improvements in past portfolio companies. A sponsor with a track record of achieving cost synergies may be trusted to add back $2–3 million; a sponsor with no history will face pushback.

The Negotiation Between Sponsor and Lender

A sophisticated lender does not accept the sponsor’s pro-forma EBITDA at face value. During the underwriting process, the lender’s analyst will:

1. Stress-test the add-backs. The sponsor claims $5 million in COGS savings. The lender assumes 60 percent realization—$3 million.

2. Question historical performance. Has the sponsor achieved these types of improvements in past deals? If yes, at what percentage of initial projections?

3. Separate categories. One-time costs are nearly certain. Cost reductions under new management are 50–70 percent likely. Aggressive synergies assuming revenue growth or major market changes are only 30–50 percent likely.

4. Calculate a blended pro-forma EBITDA. Instead of the sponsor’s $57 million, the lender might model $53 million—backing out 25 percent of the more speculative add-backs.

5. Adjust loan sizing accordingly. If the lender will only support 5 times the conservative pro-forma EBITDA, the loan is $265 million, not $285 million. The sponsor must fund the gap with more equity.

The Leverage Trap

The danger emerges when add-backs are aggressive and market conditions change. A sponsor completes a $500 million buyout with:

• Reported EBITDA: $50 million
• One-time costs add-back: $2 million (one-time severance)
• Corporate overhead add-back: $3 million (allocation no longer needed)
• Cost-reduction synergies: $5 million (new management expected to cut SG&A)
• Pro-forma EBITDA: $60 million
• Loan size: $300 million (5 times pro-forma)

In Year 1, the company achieves only $2 million of the $5 million synergies. EBITDA comes in at $52 million (reported + one-time + overhead + half the synergies). The loan is now at 5.77 times EBITDA, and covenant calculations may be tightening. In Year 2, if cost reductions stall or the market softens and revenue declines, the company could fall into covenant violation, forcing a restructuring or asset sale.

Auditing and Disclosure

Add-backs are not audited in the traditional sense. Lenders rely on sponsor representations and site visits. The sponsor and management team attest that the cost reductions are achievable, but there is no third-party verification until after the close, when results can be compared to projections.

In a well-structured deal, the purchase agreement will include reps and warranties insurance or an indemnification escrow, but these typically do not cover sponsor assumptions about future cost improvements—they cover misstatement of current facts about the target.

The result is asymmetric information. The sponsor has more detailed knowledge of which synergies are truly achievable; the lender relies on the sponsor’s reputation and past performance.

Market Variations

In strong credit markets, lenders compete aggressively for deals and accept sponsor projections more readily. Add-backs are less scrutinized. In tight credit markets, lenders demand more conservative assumptions and may reduce add-backs significantly.

For large-cap or strategic deals, where the target is a major company and the sponsor is well-known, lenders are more trusting of synergy assumptions. For lower-middle-market deals, especially in downturn periods, add-backs face greater skepticism. Some lenders adopt a rule: “No add-backs above X percent” or “Only one-time costs are added back; no recurring synergies.”

The Sponsor’s Incentive

A sponsor has a natural incentive to be optimistic about add-backs. The more pro-forma EBITDA, the larger the loan the sponsor can obtain with the same equity check. This either improves the sponsor’s returns (if the deal succeeds) or disguises the cost of a poor acquisition (if it does not). This misalignment of interest is why lenders have developed skepticism—they have seen sponsors miss add-back targets many times.

See also